<DOC>
	<DOCNO>NCT00092404</DOCNO>
	<brief_summary>The purpose trial study safety immune response measles , mumps , rubella child vaccinate investigational measles-mumps-rubella live vaccine make artificially make human protein .</brief_summary>
	<brief_title>Safety , Tolerability , Immunogenicity Investigational Vaccine With Recombinant Human Albumin ( rHA ) Children 12 18 Months Age ( V205C-009 ) ( COMPLETED )</brief_title>
	<detailed_description>The duration treatment 6 week .</detailed_description>
	<mesh_term>Rubella</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy child 12 18 month age History prior exposure measles , mumps , rubella History allergic reaction component vaccine evaluate study doctor</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>18 Months</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>